Skip to content

DAWN — Day One Biopharmaceuticals I Institutional Holders · Q2 2026

Who owns Day One Biopharmaceuticals I (DAWN)? 207 institutions reported holding $3,552 in SEC 13F filings for Q2 2026 (period ended 2026-06-30). Largest holders: IFP Advisors, Inc ($3,552), Royal Bank of Canada ($0), D. E. Shaw & Co., Inc. ($0).

RankInstitutionValueSharesChange
1IFP Advisors, Inc$3,552165Trimmed
2Royal Bank of Canada$00Exited
3D. E. Shaw & Co., Inc.$00Exited
4DEERFIELD MANAGEMENT COMPANY, L.P.$00Exited
5VANGUARD GROUP INC$00Exited
6SOROS FUND MANAGEMENT LLC$00Exited
7RENAISSANCE TECHNOLOGIES LLC$00Exited
8MAI Capital Management$00Exited
9Ameritas Investment Partners, Inc.$00Exited
10Voya Investment Management LLC$00Exited
11GLAZER CAPITAL, LLC$00Exited
12CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM$00Exited
13GABELLI FUNDS LLC$00Exited
14COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS$00Exited
15INTECH INVESTMENT MANAGEMENT LLC$00Exited
16CSS LLC/IL$00Exited
17ALLIANCEBERNSTEIN L.P.$00Exited
18RHUMBLINE ADVISERS$00Exited
19PROFUND ADVISORS LLC$00Exited
20PRUDENTIAL FINANCIAL INC$00Exited
21HARVEST MANAGEMENT LLC$00Exited
22NOMURA HOLDINGS INC$00Exited
23ARROWSTREET CAPITAL, LIMITED PARTNERSHIP$00Exited
24BNP PARIBAS FINANCIAL MARKETS$00Exited
25AQR Arbitrage LLC$00Exited

Source: SEC Form 13F filings · as of 2026-06-30